Literature DB >> 27717276

Toward precision medicine for depression: admitting ignorance and focusing on failures.

A John Rush1.   

Abstract

Entities:  

Year:  2016        PMID： 27717276      PMCID： PMC5032516          DOI： 10.1002/wps.20365

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  6 in total

1.  Narrowing the gaps between what we know and what we do in psychiatry.

Authors:  A John Rush
Journal:  J Clin Psychiatry       Date:  2015-10       Impact factor: 4.384

2.  Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.

Authors:  Jan Fawcett; A John Rush; John Vukelich; Shanna H Diaz; Lucas Dunklee; Paul Romo; Brandon C Yarns; Rodrigo Escalona
Journal:  Am J Psychiatry       Date:  2016-02-01       Impact factor: 18.112

3.  Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.

Authors:  R Uher; R H Perlis; N Henigsberg; A Zobel; M Rietschel; O Mors; J Hauser; M Z Dernovsek; D Souery; M Bajs; W Maier; K J Aitchison; A Farmer; P McGuffin
Journal:  Psychol Med       Date:  2011-09-20       Impact factor: 7.723

4.  Abandoning personalization to get to precision in the pharmacotherapy of depression.

Authors:  Roy H Perlis
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

5.  A clinical risk stratification tool for predicting treatment resistance in major depressive disorder.

Authors:  Roy H Perlis
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

6.  Toward a rational pharmacotherapy of depression.

Authors:  S L Stern; A J Rush; J Mendels
Journal:  Am J Psychiatry       Date:  1980-05       Impact factor: 18.112
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.